Navidea Biopharmaceuticals (NYSE:NAVB) announced today that it appointed two new members to its board of directors. Thomas Forest Farb-Horch and Agnieszka Winkler joined Dublin, Ohio-based Navidea’s board, effective Oct. 7, each with a three-year term ending concurrently with the company’s 2024 annual stockholders’ meeting. Get the full story at our sister site, Drug Delivery Business News.
Navidea Biopharmaceuticals (NYSE:NAVB) announced today that it made a number of changes on its board of directors. Dublin, Ohio-based Navidea ‘s chair of the board and director S. Kathryn Rouan, along with director Claudine Bruck, retired from those positions, effective immediately. Get the full story at our sister site, Drug Delivery Business News.
Navidea Biopharmaceuticals (NYSE:NAVB) announced today that it received a patent for its dextran-based drug delivery vehicles. The U.S. Patent and Trademark Office (USPTO) issued U.S. patent 11,007,272 entitled “Compounds and Methods for Diagnosis and Treatment of Viral Infections,” with protection to October 7, 2037, according to a news release. Get the full story at our sister […]
Navidea Biopharmaceuticals (NYSE:NAVB) said today that it inked a definitive asset purchase agreement with Cardinal Health (NYSE:CAH) for Navidea’s Lymphoseek product. Dublin, Ohio-based Navidea said that it will receive $80 million at closing for it’s lymphatic mapping and lymph node biopsy product, plus the opportunity for $230 million in milestone payments through 2026. More than […]
Shares in Navidea (NYSE:NAVB) rose yesterday after the company met expectations on Wall Street with its 3rd quarter results. The Dublin, Ohio-based company pared its losses by -99.3% to -$59,377 on sales of $8.5 million for the 3 months ended Sept. 30, for sales growth of 112.5% compared with the same period last year. Earnings per share were […]
Misonix CEO steps down Misonix (NSDQ:MSON) CEO Michael McManus, Jr. stepped down in early September, also leaving his post as director and chairman of the board of directors. Stavros Vizirgianakis, a member of the board of directors, is serving as the interim CEO while negotiating for a full-time position in the corner office. Vizirgiankis, who owned […]
Navidea (NYSE:NAVB) said today it is set to receive $1 million from 2 milestone payments for its Lymphoseek injection designed for lymph nodes detection. The milestone payments come from from its U.S. distribution partner Cardinal Health (NYSE:CAH) and European partner SpePharm AG, the Dublin, Ohio-based company said. The payment from Cardinal Health is based on the sale of […]
Navidea (NYSE:NAVB) said today it inked a letter of intent with Cardinal Health (NYSE:CAH) to sell its Lymphoseek injection for up to $310 million. The sale includes all current FDA-approved indications, as well as future oncology diagnostic indications in North America and other related assets, Dublin, Ohio-based Navidea said. Through the deal, Navidea is slated to receive $80 […]
Navidea (NYSE:NAVB) said today it received an offer to refinance the entirity of its existing CRG loan facility. The move will allow Navidea to refinance all of its outstanding CRG debt with a facility that will allow for “substantially more financial flexibility,” the Dublin, Ohio-based company said. “While we believe we have no obligation to refinance […]
Intuitive Surgical taps Jones for new Sr. veep of design and user experience Robotic surgery powerhouse Intuitive Surgical (NSDQ:ISRG) tagged Charles Jones as its new senior vice president of design and user experience – a new position within the company. Previous to his work at Intuitive Surgical, Jones worked at Herman Miller, Xerox, Whirlpool Corp. […]
Navidea (NYSE:NAVB) said today it is beginning the clinical trial development process as it seeks an indication for its Lymphoseek injection for treating rheumatoid arthritis and other disease states. The decision came after a recent meeting with the FDA, the Dublin, Ohio-based company said. “Our efforts to continue to unlock the significant value of the Manocept platform […]